BCIS Research & Development Working Group: CHIP-BCIS3 Trial Publication

The eagerly awaited results of the  CHIP-BCIS3 trial (of Impella use in patients undergoing high-risk percutaneous coronary intervention) are now in print in the New England of Medicine!